(Investigative Ophthalmology and Visual Science. 2001;42:1610-1616.)
© 2001
by The Association for Research in Vision and Ophthalmology, Inc.
Novel CACNA1F Mutations in Japanese Patients with Incomplete Congenital Stationary Night Blindness
Makoto Nakamura,
Sei Ito,
Hiroko Terasaki and
Yozo Miyake
From the Department of Ophthalmology, Nagoya University School of Medicine, Japan.
 |
Abstract
|
|---|
PURPOSE. Although it was reported that congenital stationary night blindness
(CSNB) could be divided into complete and incomplete CSNB clinically in
1986, it was not until 1998 that the two types were found to be
distinct clinical diseases by molecular genetic analysis. The purpose
of this article is to report mutations in the retina-specific calcium
channel
1-subunit gene (CACNA1F) in Japanese patients
with incomplete CSNB and to describe the clinical features of these
patients.
METHODS. Seven patients from five separate Japanese families with incomplete
CSNB were examined. Genomic DNA was extracted from leukocytes of the
peripheral blood, and all 48 exons of the CACNA1F were
amplified by polymerase chain reaction and directly sequenced. A
complete ophthalmic examination was performed, including best corrected
visual acuity, slit lamp and fundus examinations, fundus photography,
and electroretinography.
RESULTS. A mutation in the CACNA1F was identified in all the
patients. The identified mutations were a missense mutation
(Gly609Asp); a nonsense mutation (Arg913stop); a splice donor site
mutation of G to C at nucleotide 2571+1; a G insertion at nucleotide
709, resulting in a frame shift with a predicted stop codon at codon
247; and a 4-bp deletion at nucleotides 271 to 274, with a replacement
by an abnormal 34-bp sequence. Clinically, each patient had essentially
normal fundi, mildly reduced corrected visual acuity, and slight myopia
or hyperopia with astigmatism. Electrophysiologically, the mixed
rod-cone ERG showed a negative configuration with recordable
oscillatory potentials. The rod ERG was recordable but subnormal, and
the cone and 30-Hz flicker ERGs were markedly depressed.
CONCLUSIONS. Five novel mutations were identified in the CACNA1F in
five Japanese families with incomplete CSNB, leading to the conclusion
that in most Japanese patients, incomplete CSNB is caused by a
CACNA1F mutation.
 |
Introduction
|
|---|
The Schubert-Bornschein type of congenital stationary night
blindness (CSNB) is characterized by night blindness and the so-called
negative-type electroretinogram (ERG) in which the amplitude of the
b-wave is smaller than that of the a-wave.1
Nystagmus and
amblyopia sometimes accompany the other signs. The fundus is
essentially normal, except for high myopic changes and temporal pallor
of the optic discs.2
The symptoms appear from early
childhood and are stationary. The hereditary pattern is X-lined
recessive or autosomal recessive.
The negative-type ERG is also recorded in other diseases including
retinoschisis, Oguchi disease, fundus albipunctatus, Batten disease,
and ischemic retinal diseases such as central retinal artery occlusion.
However, these retinal diseases differ from CSNB in that they involve
fundus abnormalities, and patients with negative-type ERG without
fundus abnormalities most likely have CSNB.
In 1986, we first reported that the Schubert-Bornschein type of CSNB
could be divided clinically into two subtypes3
: the
complete type of CSNB (complete CSNB), in which rod function is
completely absent, and the incomplete type of CSNB (incomplete CSNB) in
which rod function is present but decreased.3
Since then,
we have reported other differences in the two types of CSNB, by using
various kinds of functional examinations.4
5
6
7
8
9
In 1998, the
1-subunit of the L-type calcium channel gene
(CACNA1F) located on the X chromosome was identified
as the mutated gene in incomplete CSNB by two research
groups.10
11
Mutations of CACNAIF were found in
10 of 13 families10
and in all 20 families with incomplete
CSNB.11
Since then, there has been only one study of the
genotypephenotype correlation with a known common
mutation12
; studies on additional mutations of this gene
have not been published.
There has not been a study of the genotypephenotype correlation in
nonwhite patients. The purpose of this study was to examine the
CACNA1F in seven patients from five Japanese families in
whom incomplete CSNB was clinically diagnosed. We have identified five
novel mutations in the gene in all the patients. These results
established clearly that incomplete CSNB is caused by
CACNA1F mutations in Japanese patients, some of whom were
the founders of this clinical entity.
 |
Methods
|
|---|
This study conformed to the tenets of the Declaration of
Helsinki, and informed consent was obtained from the subjects after an
explanation of the purpose of the study.
Seven patients with incomplete CSNB from five Japanese families
(referred to by the letters A through E) were analyzed. To the best of
our knowledge, the families were not related. All individuals examined
had been under observation in the Department of Ophthalmology of Nagoya
University, Japan. The ophthalmic examination included best corrected
visual acuity, refraction, biomicroscopy, ophthalmoscopy, fundus
photography, and ERG. The diagnosis in these patients was based on the
following clinical characteristics of incomplete CSNB3
:
essentially normal fundus, mildly depressed visual acuity, slightly
myopic or hyperopic refraction, and ERG abnormalities.
Electrophysiologically, the mixed rodcone ERG showed a negative
configuration with recordable oscillatory potentials. The rod ERG was
recordable but subnormal, and the cone and 30-Hz flicker ERGs were
markedly deteriorated.
Genomic DNA was extracted from leukocytes of the peripheral blood.
Exons 1 through 48 of the CACNA1F were amplified by
polymerase chain reaction (PCR) using a thermal cycler (DNA Thermal
Cycler 9700; Perkin Elmer Applied Biosystems, Foster City, CA). Primers
were purchased from Life Technologies Oriental, Inc. (Tokyo, Japan)
using the previously published sequences.10
For all exons,
200 ng genomic DNA was amplified in a 50-µl reaction with 0.5 µM of
each primer, 0.2 mM of each dNTP, and DNA polymerase
(AmpliTaq Gold; Perkin Elmer Applied Biosystems). The PCR
conditions were as follows: 5 minutes at 94°C; 35 cycles at
94°C for 30 seconds, 58°C for 30 seconds, and 72°C for 45
seconds; and a final extension step at 72°C for 7 minutes. The PCR
products were purified (High Pure PCR Purification Kit; Boehringer
Mannheim, GmbH, Mannheim, Germany) and then directly sequenced using a
DNA sequencing kit (Dye Terminator Cycle Sequencing Ready Reaction Kit;
Perkin Elmer Applied Biosystems). An automated DNA sequencer (Model
373; Applied Biosystems) was used. Primers for the sequence reaction
were the same as those for the PCR reaction. To search for
polymorphisms, exons 4, 7, 14, 15, 22, 24, 28, and 48 of the
CACNA1F from 100 alleles (34 men and 33 women) from
unrelated normal Japanese individuals were directly sequenced.
Standardized ERGs were elicited by Ganzfeld stimuli after 30 minutes of
dark adaptation. The scotopic (rod) ERGs were elicited by a blue light
at an intensity of 5.2 x
10-3 candelas
(cd)/m2 per second. The mixed rodcone
single-flash ERGs were elicited by a white stimulus at an intensity of
44.2 cd/m2 per second. The cone ERG and the 30-Hz
flicker ERG were elicited by a white stimulus at an intensity of 4
cd/m2 per second and 0.9
cd/m2 per second, respectively.
 |
Results
|
|---|
Families A, B, and E showed an X-linked recessive heredity
pattern. No family history was obtained from families C and D (Fig. 1)
. Molecular genetic examination revealed mutations of
CACNAIF in all the patients. A missense mutation of G to A
at nucleotide 1826 in exon 15 predicting a Gly609Asp amino acid
substitution was found in family A. In family B, a G insertion at
nucleotide 709 in exon 7 resulted in a frame shift with a predicted
stop codon at codon 247. A nonsense mutation of C to T at nucleotide
2737 in exon 24 resulting in the substitution of arginine to a stop at
codon 913 was detected in family C. A splice donor site mutation of G
to C at nucleotide 2571+1 in intron 22 was detected in family D. A 4-bp
deletion at nucleotides 271 to 274 was found in family E, with
insertion of an abnormal 34-bp sequence in exon 4 causing amino acid
substitution of Ser91 and Ala92 with 12 unusual residues consisting of
ValGlyValLeuHisProValGlyValLeuHisPro (Fig. 2
, Table 1
). In this study, we numbered the mutated nucleotides and substituted
amino acids according to the sequence reported by Bech-Hansen et
al.,11
which is slightly different in exons 1, 2, and 9
from that reported by Strom et al.,10
probably because of splice variants.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 1. Pedigrees of five families (designated A through E) with incomplete
CSNB showing affected (solid symbols) and unaffected
(open symbols) members. Patient numbers correspond to
those in text, Table 2
, and Figures 2
4
5
and 6
.
Arrows indicate probands. Individuals whose DNA was
tested are indicated by X. Squares, males;
circles, females; slashed symbol,
deceased; and circle with dot, carrier whose DNA was
examined.
|
|

View larger version (42K):
[in this window]
[in a new window]
|
Figure 2. Nucleotide sequences of the CACNA1F using sense primers
in the patients. Bars: positions of the mutations.
(A) A missense mutation of G to A at nucleotide 1826
(Gly609Asp) in exon 15, patient A-IV:7; (B) a G insertion at
nucleotide 709, resulting in a frame-shift stop at codon 247 in exon 7,
patient B-III:3; (C) a nonsense mutation of C to T at
nucleotide 2737 (Arg913stop) in exon 24, patient C-III:2;
(D) a splice donor site mutation of G to C at nucleotide
2571+1 in intron 22, patient D-III:4; and (E) a 4-bp
deletion at nucleotides 271 to 274 with a replacement by an abnormal
34-bp sequence, causing amino acid substitution of Ser91 and Ala92 into
12 unusual residues in exon 4, patient E-III:1.
|
|
The mutated sequence in family E was very interesting, because the
first 5-bp sequence of the insertion, 5'-GTAGG-3', was the same as the
normal antisense strand just downstream of the deletion. This was
followed by an insertion of a 13-bp sequence, 5'-GGTGCTCCACCCC-3',
which is the same sequence as the normal sense strand just upstream of
the deletion. These two kinds of abnormal sequences were repeated
sequentially twice. Furthermore, the 6-bp sequence, 5'-GGGGTG-3', which
included the joint of the two kinds of abnormal sequences, was the same
as the normal antisense strand just upstream of the deletion (Fig. 3)
.

View larger version (11K):
[in this window]
[in a new window]
|
Figure 3. Changes of the nucleotide sequence associated with nucleotides 271 to
274 del/ins 34 bp in exon 4 of the CACNA1F identified in
family E. The first 5-bp sequence of the abnormal insertion is the same
as the normal antisense strand just to the 3' side of the deletion
(lines above the nucleotide sequence), which was assumed
to be an early Okazaki fragment. The next 13-bp sequence in the
insertion is the same as the normal strand just to the 5' side of the
deletion (underline). These two abnormal sequences were
repeated twice. The 6-bp sequence of the normal antisense strand just
to the 5' side of the deletion is seen at the joint of the abnormal
sequences (dotted lines above the sequence).
|
|
All five of the mutations were novel. The segregation in family A was
confirmed, because the Gly609Asp mutation was detected in affected
patients (III:5, IV:6, and IV:7), as well as heterozygously in a female
carrier (III:6), and an unaffected member of the family (III:8) showed
a normal sequence (Fig. 4)
. In families B and D, the mothers of the patients were heterozygotes
and the fathers were normal. None of the five mutations was found in
100 normal alleles.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 4. CACNA1F mutation in family A. DNA sequences in exon 15
demonstrated a missense mutation of G to A in the three affected
members (III:5, IV:6, and IV:7). The unaffected member (III:8) showed a
normal sequence and the carrier female (III:6) was heterozygous for the
mutation.
|
|
In four families (A, B, C, and E), two nucleotide sequences were found
that differed from those in the GenBank (accession number
AJ006216; National Center for Biotechnology Information, Bethesda, MD;
available in the public domain at http//:www.ncbi.nlm.nih.gov)namely,
nucleotide 1647 C to T (Gly549Gly) in exon 14 and nucleotide 3114 T to
C (His1038His) in exon 28. These are probably polymorphisms, because
amino acid residue changes were not found. In family D, both
nucleotides were the same as those in the GenBank sequence. An
examination of exons 14 and 28 of 100 normal alleles revealed that
nucleotide 1647 is C in 40% and T in 60%, and nucleotide 3114 is C in
63% and T in 37% in Japanese subjects. In family D, a missense
sequence change of G to A at nucleotide 5594 in exon 48 predicting an
Arg1865His amino acid substitution was found in the proband (III:4) and
heterozygously in his mother (II:6). However, the probands
unaffected father (II:1) also showed this sequence change, and the
examination of exon 48 in 100 normal alleles revealed that nucleotide
5594 was G in 79% and A in 21%: G in 25 and A in 9 of the males and
homozygously G in 22 of the control females, heterozygously G and A in
10, and homozygously A in 1. We thus concluded that this mutation is
not the disease-causing mutation but a polymorphism in Japanese
subjects. Because these polymorphisms have not been reported
previously, this information will be valuable in estimating interracial
differences (Table 1)
.
The clinical characteristics of the patients are summarized in Table 2
. Fundus examination revealed no abnormalities in the posterior pole
other than the myopic changes, including the tilted discs and temporal
pallor of the optic discs (Fig. 5) . A goldish metallic reflex in the periphery was seen in patients
A-IV:7 and D-III:4. The best corrected visual acuities were mildly
reduced at between 0.2 and 0.8. (Table 2)
. The refractive errors were
mildly myopic or hyperopic, and astigmatism was present in all the
patients (Table 2)
. Nystagmus was seen in four patients, but of
different degrees (Table 2)
.

View larger version (57K):
[in this window]
[in a new window]
|
Figure 5. Fundus photographs of patients with mutations of the
CACNA1F. (A) Left eye, patient A-III:5;
(B) right eye, patient A-IV:7. The patient number and the
age (in years) are indicated in each photograph. There was no
abnormality except for myopic changes and titled discs.
|
|
The bright-flash, mixed conerod ERGs showed normal a-wave amplitude
with a significantly reduced b-wave, and oscillatory potentials (OPs)
were present (Fig. 6)
. The scotopic b-wave amplitude was reduced but clearly detectable, and
the implicit times were within the normal range in all the patients
(Fig. 6) . The photopic b-wave amplitude was significantly reduced or
were not recordable (Fig. 6)
. The amplitude of the 30-Hz
flicker ERG was also significantly reduced (Fig. 6)
.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 6. Full-field ERGs recorded after 30 minutes of dark adaptation in a
normal subject and six affected individuals. The rod ERG amplitudes
were mildly reduced, and the cone ERG amplitudes were significantly
reduced or were not recordable. The bright-flash cone-rod mixed ERG
amplitudes were the negative type in all. Arrows:
stimulus onset. The number of each patient is noted at
left.
|
|
 |
Discussion
|
|---|
The idea that the Schubert-Bornschein type of CSNB included two
different clinical entities was first proposed by our laboratory from
the results of electrophysiological examinations of Japanese
patients.3
After that, the question was raised of whether complete and incomplete CSNB were different stages of the same
clinical disease or were indeed separate diseases.13
14
15
16
With the development of molecular biology, the causative gene for the
two types of CSNB were mapped to different loci of the X chromosome:
complete CSNB on Xp.11.4 and incomplete CSNB on
Xp.11.23.17
18
Most recently, the mutated gene of
incomplete CSNB, the
1-subunit of the L-type calcium channel
gene, was identified.10
11
In addition, leucine-rich
proteoglycan nyctalopin was recently found to be the causative gene of
complete CSNB,19
20
and the difference seemed to be
resolved. However, there has not been another molecular genetic study
in patients with incomplete CSNB after the first two studies, and there
has not been a report involving nonwhite patients.
In this study, we conducted a molecular genetic analysis of Japanese
patients with incomplete CSNB, some of whom had been involved in the
identification of this disease. Mutations of the CACNA1F
were detected in all our patients, confirming the earlier
observation that incomplete CSNB is caused by CACNAIF
defects.10
11
Because we have identified
CACNA1F mutations in all the typical patients with
incomplete CSNB, we believe that in most affected Japanese persons,
incomplete CSNB is caused by CACNA1F defects. No founder
effect was observed in the five families examined; a different
mutation was detected in the each family.
Of the five novel mutations in CACNA1F and the point protein
structure, four seemed to be severe. One is a nonsense mutation
(Arg913stop) with a predicted protein missing 52.3% of the C terminus;
the second is a frame-shift mutation (nucleotide 709 ins G) that causes
premature truncation and in which 87.7% of the C terminus of the
protein would be lost with a replacement by 10 foreign amino acid
residues; the third is a splice-site mutation (nucleotide 2571+1 G to
C) that may cause a premature truncation that is missing 55.2% of the
C terminus; and the fourth (nucleotide 271-274 del/ins 34 bp) led to
in-frame insertion of 12 abnormal amino acids, which would probably
change the conformation of the protein. These mutations are likely to
result in the inability of cells to form calcium channels. Because the
clinical features in family A with Gly609Asp mutation were similar to
those with the other four mutations, the Gly609Asp mutation also was
presumed to be critical for the function of the protein. A summary
diagram of the CACNA1F protein showing all reported mutations is
presented (Fig. 7)
. We assume the other amino acid substitution, Arg1865His, does not
cause CSNB because the position is near the C terminus of the protein,
and both arginine and histidine are hydrophilic and basic.

View larger version (33K):
[in this window]
[in a new window]
|
Figure 7. Putative topology of the human retina-specific calcium channel
1-subunit. All mutations found in this study and in the previous
reports10
11
are illustrated. The known functional sites
including the dihydropyridine-binding amino acids, voltage-sensing
domains (S4), ß-subunit interaction site, and EF-hand motif are also
shown.
|
|
Based on our clinical and electrophysiological findings, there were no
significant phenotypic differences correlated with the position of the
mutation in CACNA1F. However, additional data from the
long-term follow-up of the patients is needed for an exact
genotypephenotype correlation and to determine whether this disease
is associated with retinal atrophy or progressive degeneration.
Actually, although one of the characteristics of CSNB is normal fundi,
we recently examined some patients with retinal atrophy or abnormality
in whom the CACNA1F was mutated. The details of these cases
will be presented (manuscript in preparation).
The mutation in family E with a 4-bp deletion and 34-bp insertion
seemed to be very unusual. Because the 5-bp sequence on the 5' end of
this insertion is the same as that of the normal antisense strand just
downstream of the deletion, the cause of this mutation was assumed to
be an early Okazaki fragment.21
This mutation may have
resulted during DNA replication. For eye diseases, there is only one
mutation reported in which a possible early Okazaki fragment was found,
in a family with X-linked retinoschisis.21
The CACNA1F is expressed only in the
retina.10
11
It is expressed strongly in the outer and
inner nuclear layers as well as weakly in the ganglion
cells.10
Calcium channel
1-subunits form the calcium
channel, together with
2-, ß1-, ß2-,
- and
-subunits, and
the
1-subunits are considered to function as pore and voltage
sensors.22
23
It is assumed that abnormal molecules of the
1-subunits can result in the impairment of the influx of
Ca2+ that is required for the release of
glutamate as a neurotransmitter from the photoreceptor cells. This
would result in the reduction of signal transfer to the ON-bipolar
cells.10
11
Thus, the ON-bipolar cells would be
continuously depolarized, and secondarily, the Müller cells would
be depolarized. Because the ERG b-wave originates from the Müller
cells and the depolarizing ON-bipolar cells, this mechanism is
suggested to be the reason for the decreased b-wave amplitude as well
as the night blindness in incomplete CSNB.10
11
However, the exact pathogenesis of incomplete CSNB is still not known.
We have evidence that the off pathway is abnormal in incomplete CSNB,
because the off responses were selectively diminished when the on- and
off-responses of photopic ERG were recorded, with rectangular light
stimuli in patients with incomplete CSNB.4
24
This
observation is supported by the similarity in the shape of the
responses elicited by rectangular light stimuli when ±
cis-2,3-piperidine dicarboxylic acid (PDA) or kynurenic acid
(KYN) were injected into the vitreous of experimental animals. These
two agents selectively block signal transmission between the
photoreceptors and OFF-bipolar cells.25
Furthermore, the
blue cone ERG, which is made up of only the ON-pathway, are recordable
in incomplete CSNB,26
whereas it is not recordable in
complete CSNB.26
27
These observations have led us to suggest that the pathogenesis of
incomplete CSNB is mainly a blockage of signal transfer from
photoreceptors to OFF-bipolar cells. If this hypothesis is correct, the
calcium channel abnormality may cause the reduction of the release of
glutamate from the cone photoreceptors, leading to a failure to
hyperpolarize the OFF-bipolar cells. In such cases, the reason for the
night blindness in incomplete CSNB may be the dysfunction of signaling
from rods proximal to the bipolar cells. The basis for this suggestion
is the abnormal scotopic threshold response (STR)8
that is
thought to be generated around the inner plexiform layer or between the
inner plexiform layer and ganglion cells and is thought to reflect the
function of rod signaling proximal to the bipolar
cells.28
29
30
It is not clear whether the pathogenesis of incomplete CSNB is due to
the continuous depolarization of ON-bipolar cells, or to the
obstruction of the off pathway, or to both. Evidence to support one of
these explanations should be obtained with additional studies on the
localization and the determination of the function of the
CACNA1F.
 |
Acknowledgements
|
|---|
The authors thank Alfons Meindl, PhD, for helpful information about
the primers for mutation analysis of the CACNA1F.
 |
Footnotes
|
|---|
Supported by the Grants for Research Committee on Chorioretinal Degenerations from the Ministry of Health and Welfare of Japan, and Grant-in-Aid for Scientific Research B11470363 (YM) and C12671703 (MN) from the Ministry of Education, Science, Sports, and Culture, Japan.
Submitted for publication January 4, 2001; accepted February 16, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Makoto Nakamura, Department of Ophthalmology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan. makonaka{at}med.nagoya-u.ac.jp
 |
References
|
|---|
-
Schubert, G, Bornschein, H. (1952) Beitrag zur. Analyse des menschlichen Electroretinogram [in German] Ophthalmologica 123,396-413[Medline][Order article via Infotrieve]
-
Heckenlively, JR, Martin, DA, Rosenbaum, AL (1983) Loss of electroretinographic oscillatory potentials, optic atrophy, and dysplasia in congenital stationary night blindness Am J Ophthalmol 96,526-534[Medline][Order article via Infotrieve]
-
Miyake, Y, Yagasaki, K, Horiguchi, M, Kawase, Y, Kanda, T. (1986) Congenital stationary night blindness with negative electroretinogram: a new classification Arch Ophthalmol 104,1013-1020[Medline][Order article via Infotrieve]
-
Miyake, Y, Yagasaki, K, Horiguchi, M, Kawase, Y. (1987) On- and off-responses in photopic electroretinogram in complete and incomplete types of congenital stationary night blindness Jpn J Ophthalmol 31,81-87[Medline][Order article via Infotrieve]
-
Miyake, Y, Yagasaki, K, Horiguchi, M. (1987) A rod-cone dysfunction syndrome with separate clinical entity: incomplete-type congenital stationary night blindness Prog Clin Biol Res 247,137-145[Medline][Order article via Infotrieve]
-
Miyake, Y, Horiguchi, M, Ota, I, Shiroyama, N. (1987) Characteristic ERG-flicker anomaly in incomplete congenital stationary night blindness Invest Ophthalmol Vis Sci 28,1816-1823[Abstract/Free Full Text]
-
Miyake, Y. (1989) X-linked congenital stationary night blindness Arch Ophthalmol 107,635-636[Medline][Order article via Infotrieve]
-
Miyake, Y, Horiguchi, M, Terasaki, H, Kondo, M. (1994) Scotopic threshold response in complete and incomplete types of congenital stationary night blindness Invest Ophthalmol Vis Sci 35,3770-3775[Abstract/Free Full Text]
-
Terasaki, H, Miyake, Y, Nomura, R, Horiguchi, M, Suzuki, S, Kondo, M. (1999) Blue-on-yellow perimetry in the complete type of congenital stationary night blindness Invest Ophthalmol Vis Sci 40,2761-2764[Abstract/Free Full Text]
-
Strom, TM, Nyakatura, G, Apfelstedt-Sylla, E, et al (1998) An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness Nat Genet 19,260-263[Medline][Order article via Infotrieve]
-
Bech-Hansen, NT, Naylor, MJ, Maybaum, TA, et al (1998) Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness Nat Genet 19,264-267[Medline][Order article via Infotrieve]
-
Boycott, KM, Pearce, WG, Bech-Hansen, NT (2000) Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F Can J Ophthalmol 35,204-213[Medline][Order article via Infotrieve]
-
Weleber, RG, Pillers, DA, Powell, BR, Hanna, CE, Magenis, RE, Buist, NR (1989) Aland Island eye disease (Forsius-Eriksson syndrome) associated with contiguous deletion syndrome at Xp21: similarity to incomplete congenital stationary night blindness Arch Ophthalmol 107,1170-1179[Medline][Order article via Infotrieve]
-
Rosenberg, T, Schwartz, M, Simonsen, SE (1990) Aland eye disease (Forsius-Eriksson-Miyake syndrome) with probability established in a Danish family Acta Ophthalmol (Copenh) 68,281-291[Medline][Order article via Infotrieve]
-
Khouri, G, Mets, MB, Smith, VC, Wendell, M, Pass, AS (1988) X-linked congenital stationary night blindness: review and report of a family with hyperopia Arch Ophthalmol 106,1417-1422[Medline][Order article via Infotrieve]
-
Leys, MJ, Mendonca-Costa, RH, de Rouck, AF, Odom, JV (1993) Congenital stationary night blindness (CSNB): how distinct are the complete and incomplete types [ARVO Abstract]? Invest Ophthalmol Vis Sci 34(4),S1369Abstract nr 3292
-
Bergen, AA, ten Brink, JB, Riemslag, F, et al (1996) Conclusive evidence for a distinct congenital stationary night blindness locus in Xp21.1 J Med Genet 33,869-872[Abstract/Free Full Text]
-
Hardcastle, AJ, David-Gray, ZK, Jay, M, Bird, AC, Bhattacharya, SS (1997) Localization of CSNBX (CSNB4) between the retinitis pigmentosa loci RP2 and RP3 on proximal Xp Invest Ophthalmol Vis Sci 38,2750-2755[Abstract/Free Full Text]
-
Bech-Hansen, NT, Naylor, MJ, Maybaum, TA, et al (2000) Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness Nat Genet 26,319-323[Medline][Order article via Infotrieve]
-
Pusch, CM, Zeitz, C, Brandau, O, et al (2000) The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein Nat Genet 26,324-327[Medline][Order article via Infotrieve]
-
Rodriguez, IR, Mazuruk, K, Jaworski, C, Iwata, F, Moreira, EF, Kaiser-Kupfer, MI (1998) Novel mutations in the XLRS1 gene may be caused by early Okazaki fragment sequence replacement Invest Ophthalmol Vis Sci 39,1736-1739[Abstract/Free Full Text]
-
Catterall, WA (1995) Structure and function of voltage-gated ion channels Annu Rev Biochem 64,493-531[Medline][Order article via Infotrieve]
-
Mikami, A, Imoto, K, Tanabe, T, et al (1989) Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel Nature 340,230-233[Medline][Order article via Infotrieve]
-
Quigley, M, Roy, MS, Barsoum-Homsy, M, Chevrette, L, Jacob, JL, Milot, J (199697) On- and off-responses in the photopic electroretinogram in complete-type congenital stationary night blindness Doc Ophthalmol 92,159-165[Medline][Order article via Infotrieve]
-
Sieving, PA (1993) AOS thesis: photopic ON-and OFF-pathway abnormalities in retinal dystrophies Trans Am Ophthalmol Soc 91,701-773[Medline][Order article via Infotrieve]
-
Miyake, Y, Horiguchi, M, Suzuki, S, Kondo, M, Tanikawa, A. (1997) Complete and incomplete type congenital stationary night blindness (CSNB) as a model of "off-retina" and "on-retina" LaVail, M eds. Degenerative Retinal Disease ,31-41 Plenum Press New York.
-
Kamiyama, M, Yamamoto, S, Nitta, K, Hayasaka, S. (1996) Undetectable S cone electroretinogram b-wave in complete congenital stationary night blindness Br J Ophthalmol 80,637-639[Abstract/Free Full Text]
-
Sieving, PA, Frishman, LJ, Steinberg, RH (1986) Scotopic threshold response of proximal retina in cat J Neurophysiol 56,1049-1061[Abstract/Free Full Text]
-
Wakabayashi, K, Gieser, J, Sieving, PA (1988) Aspartate separation of the scotopic threshold response (STR) from the photoreceptor a-wave of the cat and monkey ERG Invest Ophthalmol Vis Sci 29,1615-1622[Abstract/Free Full Text]
-
Frishman, LJ, Sieving, PA, Steinberg, RH (1988) Contributions to the electroretinogram of currents originating in proximal retina Vis Neurosci 1,307-315[Medline][Order article via Infotrieve]
This article has been cited by other articles:

|
 |

|
 |
 
R. Jalkanen, N. T. Bech-Hansen, R. Tobias, E.-M. Sankila, M. Mantyjarvi, H. Forsius, A. de la Chapelle, and T. Alitalo
A Novel CACNA1F Gene Mutation Causes Aland Island Eye Disease
Invest. Ophthalmol. Vis. Sci.,
June 1, 2007;
48(6):
2498 - 2502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R Jalkanen, M Mantyjarvi, R Tobias, J Isosomppi, E-M Sankila, T Alitalo, and N T Bech-Hansen
X linked cone-rod dystrophy, CORDX3, is caused by a mutation in the CACNA1F gene
J. Med. Genet.,
August 1, 2006;
43(8):
699 - 704.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Lin, K M Nishiguchi, M Nakamura, T P Dryja, E L Berson, and Y Miyake
Recessive mutations in the CYP4V2 gene in East Asian and Middle Eastern patients with Bietti crystalline corneoretinal dystrophy
J. Med. Genet.,
June 1, 2005;
42(6):
e38 - e38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hemara-Wahanui, S. Berjukow, C. I. Hope, P. K. Dearden, S.-B. Wu, J. Wilson-Wheeler, D. M. Sharp, P. Lundon-Treweek, G. M. Clover, J.-C. Hoda, et al.
A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation
PNAS,
May 24, 2005;
102(21):
7553 - 7558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ito, M. Nakamura, Y. Nuno, Y. Ohnishi, T. Nishida, and Y. Miyake
Novel Complex GUCY2D Mutation in Japanese Family with Cone-Rod Dystrophy
Invest. Ophthalmol. Vis. Sci.,
May 1, 2004;
45(5):
1480 - 1485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakamura, S. Ito, C.-H. Piao, H. Terasaki, and Y. Miyake
Retinal and Optic Disc Atrophy Associated With a CACNA1F Mutation in a Japanese Family
Arch Ophthalmol,
July 1, 2003;
121(7):
1028 - 1033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Ball, P. A. Powers, H.-S. Shin, C. W. Morgans, N. S. Peachey, and R. G. Gregg
Role of the {beta}2 Subunit of Voltage-Dependent Calcium Channels in the Retinal Outer Plexiform Layer
Invest. Ophthalmol. Vis. Sci.,
May 1, 2002;
43(5):
1595 - 1603.
[Abstract]
[Full Text]
[PDF]
|
 |
|